Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Olaparib|DRUG: 17b-estradiol
Sponsor: Mary D Chamberlin
Collaborators: Dartmouth-Hitchcock Medical Center